As of 2025-09-18, the EV/EBITDA ratio of AtriCure Inc (ATRC) is -296.16. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AtriCure's latest enterprise value is 1,691.95 mil USD. AtriCure's TTM EBITDA according to its financial statements is -5.71 mil USD. Dividing these 2 quantities gives us the above AtriCure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 15.1x | 11.6x |
| Forward P/E multiples | 17.6x - 24.3x | 18.2x |
| Fair Price | (1.05) - (0.77) | (0.75) |
| Upside | -103.0% - -102.2% | -102.1% |
| Date | EV/EBITDA |
| 2025-09-16 | -304.42 |
| 2025-09-15 | -292.85 |
| 2025-09-12 | -296.68 |
| 2025-09-11 | -318.34 |
| 2025-09-10 | -297.38 |
| 2025-09-09 | -305.73 |
| 2025-09-08 | -304.77 |
| 2025-09-05 | -299.38 |
| 2025-09-04 | -301.81 |
| 2025-09-03 | -294.07 |
| 2025-09-02 | -307.29 |
| 2025-08-29 | -313.38 |
| 2025-08-28 | -315.38 |
| 2025-08-27 | -316.08 |
| 2025-08-26 | -321.04 |
| 2025-08-25 | -320.78 |
| 2025-08-22 | -319.21 |
| 2025-08-21 | -302.42 |
| 2025-08-20 | -305.38 |
| 2025-08-19 | -303.38 |
| 2025-08-18 | -301.47 |
| 2025-08-15 | -299.99 |
| 2025-08-14 | -299.64 |
| 2025-08-13 | -310.86 |
| 2025-08-12 | -303.38 |
| 2025-08-11 | -300.38 |
| 2025-08-08 | -298.77 |
| 2025-08-07 | -303.90 |
| 2025-08-06 | -309.29 |
| 2025-08-05 | -318.17 |
| 2025-08-04 | -307.82 |
| 2025-08-01 | -290.94 |
| 2025-07-31 | -296.94 |
| 2025-07-30 | -297.20 |
| 2025-07-29 | -267.62 |
| 2025-07-28 | -280.59 |
| 2025-07-25 | -265.62 |
| 2025-07-24 | -254.05 |
| 2025-07-23 | -259.71 |
| 2025-07-22 | -247.09 |
| 2025-07-21 | -245.96 |
| 2025-07-18 | -246.14 |
| 2025-07-17 | -250.40 |
| 2025-07-16 | -255.88 |
| 2025-07-15 | -257.27 |
| 2025-07-14 | -263.88 |
| 2025-07-11 | -258.84 |
| 2025-07-10 | -270.50 |
| 2025-07-09 | -269.28 |
| 2025-07-08 | -266.75 |